Poxviruses Clinical Presentation

  • Author: John D Shanley, MD, MPH; Chief Editor: Burke A Cunha, MD   more...
 
Updated: Dec 5, 2011
 

History

Among poxvirus infections, variola and molluscum contagiosum are diseases of humans. Vaccinia results from either vaccination or accidental laboratory exposure. Other poxvirus infections are zoonoses, resulting from close animal exposure.

  • Smallpox
    • Smallpox generally presents in 2 clinical forms, variola major (25-30% fatality rate) and a similar but milder disease known as variola minor (< 1% fatality rate).
    • Patients with smallpox initially present with nonspecific symptoms, including fever and a toxic appearance. These symptoms are followed by a slow developing maculopapular rash, which generally develops on the face and extremities and spreads to the trunk. The rash evolves rapidly into vesicles, followed by pustules, scabs, and healing.
    • Some patients present with unusual forms of variola. Flat smallpox is a severe form in which the pustules remain relatively flat. Hemorrhagic variola is a syndrome that appears clinically similar to meningococcemia. This form is invariably fatal.
  • Molluscum contagiosum
    • Patients infected with molluscum contagiosum develop small pearly epidermal nodules (1-2 mm in diameter) that have a characteristic central pit known as an umbilication.
    • This condition generally resolves over time. However, persons with immunodeficiency (eg, HIV infection) who develop molluscum contagiosum may develop chronic and extensive skin lesions.
  • Vaccinia
    • Vaccinia infections result from iatrogenic or accidental inoculation of the virus.
    • Infections have been described at multiple sites, including the eyes. On the skin, the infection initially appears as localized maculopapular lesions that evolve into vesicles and pustules, which then form a scab. Healing may be associated with significant scarring. The CDC has provided an excellent training program on vaccinia vaccination and adverse events (Smallpox Vaccination and Adverse Events Training Module).
    • Patients with vaccinia infections may have fever and regional lymphadenopathy.
    • In patients with eczema (ie, active or inactive), vaccinia can cause eczema vaccinatum. Infection involves the eczematous skin, and areas become intensely inflamed. The infection may disseminate. Constitutional symptoms are severe, with high fever and generalized lymphadenopathy. Death is common.
    • In immunodeficient patients, vaccinia is known to cause progressive vaccinia. The initial site of inoculation develops a progressive unrelenting lesion known as vaccinia gangrenosum. Dissemination of vaccinia can occur with generalized lesions. Death is common in these patients. See the images below. Poxviruses. Following vaccination for smallpox, thPoxviruses. Following vaccination for smallpox, this patient with chronic lymphocytic leukemia developed vaccinia gangrenosum. Poxviruses. Following vaccination for smallpox, a Poxviruses. Following vaccination for smallpox, a patient with chronic lymphocytic leukemia developed vaccinia gangrenosum. The lesion was on the left shoulder. As the lesion progressed, the patient also developed evidence of dissemination. This image shows a vaccinia pustule on the foot.
  • Monkeypox infection can produce a disease similar to variola minor characterized by a disseminated rash or relatively localized lesions. Clinically, disseminated monkeypox infection cannot be distinguished from smallpox. Monkeypox infections generally occur in villages in tropical regions of western and central Africa. Most of the monkeypox infections that occurred during the US outbreak in 2003 were characterized by localized lesions (Marshfield Clinic Monkeypox Virus Information).
  • Other human poxvirus infections include cowpox, orf (ie, contagious pustular dermatitis), bovine papular stomatitis, pseudocowpox (milker's nodule), sealpox, tanapox, and yabapox. These are rare zoonotic infections that are caused by cutaneous inoculation due to the close proximity of humans to animals. Cowpox causes a localized pustular skin lesion that follows a course similar to that of uncomplicated vaccinia infection. The remainder of the infections produce a localized nodular lesion that resolves over time.
Next

Physical

Poxvirus infections cause either a localized or a generalized vesicular exanthem. The lesions of smallpox, vaccinia, monkeypox, and cowpox evolve from a papule to a vesicle. The vesicles then form pustules, followed by scabbing and healing. The remaining viruses cause localized nodules at the site of inoculation. Individual viruses cause characteristic clinical syndromes. With the exception of smallpox, regional lymphadenopathy is common.

Previous
Next

Causes

Exposure to poxviruses (members of the Poxviridae family) causes these infections.

Previous
 
 
Contributor Information and Disclosures
Author

John D Shanley, MD, MPH  Professor Emeritus, University of Connecticut; Professor of Preventive Medicine, Stony Brook Medical Center

John D Shanley, MD, MPH is a member of the following medical societies: American Association for the Advancement of Science, American Society for Microbiology, American Society of Tropical Medicine and Hygiene, and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Specialty Editor Board

Larry I Lutwick, MD  Professor of Medicine, State University of New York Downstate Medical School; Director, Infectious Diseases, Veterans Affairs New York Harbor Health Care System, Brooklyn Campus

Larry I Lutwick, MD is a member of the following medical societies: American College of Physicians and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Charles V Sanders, MD  Edgar Hull Professor and Chairman, Department of Internal Medicine, Professor of Microbiology, Immunology and Parasitology, Louisiana State University School of Medicine at New Orleans; Medical Director, Medicine Hospital Center, Charity Hospital and Medical Center of Louisiana at New Orleans; Consulting Staff, Ochsner Medical Center

Charles V Sanders, MD is a member of the following medical societies: Alliance for the Prudent Use of Antibiotics, Alpha Omega Alpha, American Association for the Advancement of Science, American Association of University Professors, American Clinical and Climatological Association, American College of Physician Executives, American College of Physicians, American Federation for Medical Research, American Foundation for AIDS Research, American Geriatrics Society, American Lung Association, American Medical Association, American Society for Microbiology, American Thoracic Society, American Venereal Disease Association, Association for Professionals in Infection Control and Epidemiology, Association of American Medical Colleges, Association of American Physicians, Association of Professors of Medicine, Infectious Disease Society for Obstetrics and Gynecology, Infectious Diseases Society of America, Louisiana State Medical Society, Orleans Parish Medical Society, Royal Society of Medicine, Sigma Xi, Society of General Internal Medicine, Southeastern Clinical Club, Southern Medical Association, Southern Society for Clinical Investigation, and Southwestern Association of Clinical Microbiology

Disclosure: Baxter International and Johnson & Johnson Royalty Other

Eleftherios Mylonakis, MD  Clinical and Research Fellow, Department of Internal Medicine, Division of Infectious Diseases, Massachusetts General Hospital

Eleftherios Mylonakis, MD is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians, American Society for Microbiology, and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Chief Editor

Burke A Cunha, MD  Professor of Medicine, State University of New York School of Medicine at Stony Brook; Chief, Infectious Disease Division, Winthrop-University Hospital

Burke A Cunha, MD is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

References
  1. Preston R. The Demon in the Freezer. In: The New Yorker. July 12, 1999:44-61. [Full Text].

  2. Kile JC, Fleischauer AT, Beard B, et al. Transmission of monkeypox among persons exposed to infected prairie dogs in Indiana in 2003. Arch Pediatr Adolesc Med. Nov 2005;159(11):1022-5. [Medline].

  3. De Clercq E, Neyts J. Therapeutic potential of nucleoside/nucleotide analogues against poxvirus infections. Rev Med Virol. Sep-Oct 2004;14(5):289-300. [Medline].

  4. Meadows KP, Tyring SK, Pavia AT, et al. Resolution of recalcitrant molluscum contagiosum virus lesions in human immunodeficiency virus-infected patients treated with cidofovir. Arch Dermatol. Aug 1997;133(8):987-90. [Medline].

  5. Ibarra V, Blanco JR, Oteo JA, et al. Efficacy of cidofovir in the treatment of recalcitrant molluscum contagiosum in an AIDS patient. Acta Derm Venereol. Jul-Aug 2000;80(4):315-6. [Medline].

  6. Geerinck K, Lukito G, Snoeck R, et al. A case of human orf in an immunocompromised patient treated successfully with cidofovir cream. J Med Virol. Aug 2001;64(4):543-9. [Medline].

  7. Baxby D, Bennett M. Poxvirus zoonoses. J Med Microbiol. Jan 1997;46(1):17-20, 28-33. [Medline].

  8. Di Giulio DB, Eckburg PB. Human monkeypox: an emerging zoonosis. Lancet Infect Dis. Jan 2004;4(1):15-25. [Medline].

  9. Fenner F. Adventures with poxviruses of vertebrates. FEMS Microbiol Rev. Apr 2000;24(2):123-33. [Medline].

  10. Fenner F. Poxviruses. In: Richman D, Whitley RJ, Hayden FG, eds. Clinical Virology. ed. New York, NY: Churchill Livingstone; 1996:357-74.

  11. Fenner F, Henderson DH, Arita I, et al. Smallpox and its eradication. Geneva, Switzerland: World Health Organization.; 1988.

  12. Henderson DA, Inglesby TV, Bartlett JG, et al. Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA. Jun 9 1999;281(22):2127-37. [Medline].

  13. Henderson DH, Moss B. Smallpox and vaccinia. In: Plotkin S, Orenstein WA, eds. Vaccines. 3rd. Philadelphia, Pa: WB Saunders; 1999:74-97.

  14. Lewis-Jones S. Zoonotic poxvirus infections in humans. Curr Opin Infect Dis. Apr 2004;17(2):81-9. [Medline].

  15. Perna AG, Tyring SK. A review of the dermatologic manifestations of poxvirus infections. Dermatol Clin. Apr 2002;20(2):343-6. [Medline].

  16. Slifka MK, Hanifin JM. Smallpox: the basics. Dermatol Clin. Jul 2004;22(3):263-74, vi. [Medline].

Previous
Next
 
Poxviruses. Following vaccination for smallpox, this patient with chronic lymphocytic leukemia developed vaccinia gangrenosum.
Poxviruses. Following vaccination for smallpox, a patient with chronic lymphocytic leukemia developed vaccinia gangrenosum. The lesion was on the left shoulder. As the lesion progressed, the patient also developed evidence of dissemination. This image shows a vaccinia pustule on the foot.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.